SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9038)6/3/1998 5:39:00 PM
From: RealMuLan  Read Replies (1) | Respond to of 23519
 
It is amazing that this one no-name analyst's downgrade had THREE press releases on Yahoo.



To: VLAD who wrote (9038)6/4/1998 8:18:00 AM
From: Perry  Respond to of 23519
 
<<They mention that the Pain Webber Anal_yst gave a -.45 estimate for Q2 yesterday. They
mention how bad the script numbers are. They show how bad the chart appears. But little else is said.>>>

What else could be said for a drug that hardly works and must be pushed up the urethra! Anything else that could be said would surely be bad! As I said before PFE and all the other new ED drugs will eat VVUS's market share.

Perry


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News